Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Participants were contacted by phone at week 4 to review product compliance, completion of the exercise behavior scale, concomitant therapies, adverse events and study requirements
GLP-1 treatment for diabetes and obesity Semaglutide, a GLP-1 receptor agonist, is the active ingredient in Ozempic for diabetes and in Wegovy for obesity
We will offer a comprehensive program in the future
Extended-release versions include strengths such as 50/500, 50/1000, and 100/1000, depending on the specific product label and market
Email: [email protected]
US$ 29.52
US$ 20.93
US$ 21.52
US$ 22.81
US$ 29.75
US$ 20.63
